The Asia Pacific Burn Ointment Market would witness market growth of 7% CAGR during the forecast period (2020-2026). The risk of hospital-acquired infections (HAI) is one of the major challenges that is faced by patients with burn injuries. The highest revenue in the burn injury treatment market is generated from hospitals. The healthcare providers in hospitals and clinics are providing topical treatments in order to reduce the incidences of hospital-acquired infections.
To prevent the risk of hospital-acquired infection (HAI) in patients, companies involved in manufacturing healthcare products including burn injury treatment are bringing improved silver sulfadiazine (SSD) creams that minimize complications and other health risks. Healthcare professionals are looking towards the expertise of scientists and researchers to do experiments on silver-containing dressings with honey, since honey offers antiseptic effects that causes faster healing of burn injuries. Healthcare companies are focused to increase their research on dressings infused with sodium hypochlorite that may give faster healing results if compared to SSD dressings.
As the number of cases of blaze wounds is increasing, the demand for its treatment options are also increasing and therefore in coming years the overall healthcare expenditure on blaze wound care is expected to rise. The blaze wound care can be treated by using biologics, advanced dressings, and traditional blaze wound care products. In both hospitals and home-care settings, burn ointments are used as first aid.
Based on Depth of Burn, the market is segmented into Minor Burns, Partial Thickness Burns and Full Thickness Burns. Based on Product, the market is segmented into Topical Antibiotics, Silver, Iodine and Other Products. Based on End Use, the market is segmented into Clinics, Hospitals and Other End Use. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: Burn Ointment Market in Asia Pacific is expected to register a CAGR of 7% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.
By Depth of Burn
By Product
By End Use
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
